Published September 21, 2023
0 views Journal article Open Access Open Access

Increased Risk of Vertebral Fractures in Patients With Mild Autonomous Cortisol Secretion.

  • 1. Department of Medical Biotechnology and Translational Medicine, University of Milan, 20100 Milan, Italy.
  • 2. University of Milan
  • 3. Unit of Endocrinology, Fondazione IRCCS Cà Granda-Ospedale Maggiore Policlinico, 20100 Milan, Italy.
  • 4. Scientific Institute for Research, Hospitalization and Healthcare
  • 5. Endocrinology Department of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, 20100 Milan, Italy.
  • 6. Unit of Endocrinology and Metabolism, University-Hospital S. Maria Della Misericordia, 33100 Udine, Italy.
  • 7. Unit of Endocrinology, "Casa Sollievo della Sofferenza," Hospital, IRCCS, San Giovanni Rotondo, 71013 Foggia, Italy.
  • 8. Department of Biomedical, Surgical and Dental Sciences, University of Milan, 20100 Milan, Italy.
  • 9. Department of Medical and Surgical Sciences, Fondazione Policlinico Universitario A. Gemelli, 00100 Rome, Italy.
  • 10. Dipartimento di Medicina Clinica e Chirurgia, Unità di Endocrinologia, Andrologia e Diabetologia - University of Naples "Federico II", 80131 Naples, Italy.
  • 11. University of Naples Federico II
  • 12. UNESCO Chair "Education for Health and Sustainable Development", University of Naples "Federico II", 80131 Naples, Italy.
  • 13. Unit of Endocrinology, ASST Grande Ospedale Metropolitano Niguarda, 20162 Milan, Italy.

Description

The risk of vertebral fractures (VFx) in patients with adrenal incidentalomas (AI) and mild autonomous cortisol secretion (MACS) is debated. To evaluate the VFx prevalence and incidence in patients with AI and MACS. This cross-sectional and longitudinal study using retrospective data from 4 Italian endocrinology units included 444 patients (cross-sectional arm) and 126 patients (longitudinal arm, 24.9 ± 5.3 months follow-up) to evaluate prevalent and incident VFx, respectively, in patients with MACS (MACS-yes) and without MACS (MACS-no). The main outcome measures were serum cortisol after a 1-mg dexamethasone test (F-1mgDST), bone mineral density (BMD) by dual-energy x-ray absorptiometry at spine (LS) and femur (FN), and VFx presence by x-ray. Cross-sectional arm: 214 and 230 patients were MACS-yes and MACS-no, respectively, based on F-1mgDST >1.8 µg/dL (50 nmol/L). Patients with MACS had higher VFx prevalence (62.6%) than those without MACS (22.9%, P < .001); MACS was associated with prevalent VFx (odds ratio, 5.203; 95% CI, 3.361-8.055; P < .001; relative risk [RR] 2.07), regardless of age, body mass index, gender distribution, LS-BMD, and presence of type 2 diabetes mellitus (T2D). Longitudinal arm: 66 and 60 patients were MACS-no and MACS-yes, respectively. Patients without MACS showed higher number of incident VFx (36.4%) than patients without MACS (10.0%, P < .001); MACS was associated with the presence of an incident VFx (RR 4.561; 95% CI, 1.600-13.003; P = .005) regardless of age, LS-BMD, gender distribution, presence of prevalent VFx, and T2D. Results were confirmed in women and men when separately evaluated. Women and men with AI and MACS are at higher risk of VFx. © The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society.
Enabled by The Lens

Open Access

Licence Attribution (CC BY)
Publisher Website Access full text